238 results on '"Kronbichler, Andreas"'
Search Results
2. Nonlupus Full House Nephropathy: A Systematic Review
3. National trends in the prevalence of chronic kidney disease among Korean adults, 2007–2020
4. The COVID-19 Pandemic: A Special Challenge for the Journalʼs Editors
5. Development of a Kidney Prognostic Score in a Japanese Cohort of Patients With Antineutrophil Cytoplasmic Autoantibody Vasculitis
6. Diagnosis and management of ANCA-associated vasculitis
7. The impact of urinary incontinence on multiple health outcomes: an umbrella review of meta-analysis of observational studies
8. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
9. Exercise-Induced Fluid Retention, Cardiac Volume Overload, and Peripheral Edema in Ultra-Distance Cyclists
10. Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
11. From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies
12. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
13. Glomerular Diseases Across Lifespan: Key Differences in Diagnostic and Therapeutic Approaches
14. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management
15. Differential expression of MicroRNAs in Alzheimer’s disease: a systematic review and meta-analysis
16. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review
17. Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study
18. Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023.
19. EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association–Immunonephrology Working Group (ERA-IWG) perspective.
20. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
21. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD
22. Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study
23. Author Correction: Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
24. Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group.
25. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study.
26. Edema-like symptoms are common in ultra-distance cyclists and driven by overdrinking, use of analgesics and female sex – a study of 919 athletes
27. Improving outcomes in glomerular disease
28. Correction: Differential expression of MicroRNAs in Alzheimer’s disease: a systematic review and meta-analysis
29. “Atypical” Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?
30. Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases—not yet ready for prime time!
31. EULAR recommendations for the management of ANCA- associated vasculitis: 2022 update.
32. The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseases.
33. Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxis.
34. Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations.
35. Why do people cycle (a lot)? A multivariate approach on mental health, personality traits and motivation as determinants for cycling ambition.
36. Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
37. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicenter retrospective case-control study
38. Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG).
39. Challenges of defining renal response in ANCA-associated vasculitis: call to action?
40. Avacopan for ANCA-associated vasculitis – information for prescribers.
41. Risk factors for serious infections in ANCA-associated vasculitis.
42. Novel aspects in the pathophysiology and diagnosis of glomerular diseases.
43. Clinical Characteristics and Outcome of ANCA-Associated Vasculitides Induced by Anti-Thyroid Drugs: A Multicenter Retrospective Cohort Study
44. Impact of data extraction errors in meta-analyses on the association between depression and peripheral inflammatory biomarkers: an umbrella review.
45. The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021.
46. Using a Network-Based Analysis Approach to Investigate the Involvement of S. aureus in the Pathogenesis of Granulomatosis with Polyangiitis.
47. Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.
48. The Sound of Interconnectivity; The European Vasculitis Society 2022 Report
49. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis
50. WCN24-369 End-stage kidney disease care for migrants: a European survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.